CTNI-36. INITIATION OF A PHASE 1 DOSE-ESCALATING STUDY OF WEEKLY DIRECT-TO-BRAIN ADMINISTRATION OF SOLUBILISED FORMULATION OF PANOBINOSTAT (MTX110) IN PATIENTS WITH RECURRENT GLIOBLASTOMA (MAGIC-G1 STUDY)

Authors: Annick Desjardins, Kelly Conlon, Hannah Gunning, Rhian Davies, Jordan Komisarow, Robert Cavaliere, Dmitry Zamoryakhin

Published: 2022-11-14

DOI: 10.1093/neuonc/noac209.301

Source: Full article